Danish Cooperative Study

Completed

Phase N/A Results

Summary of Purpose

To determine if acetylsalicylic acid (ASA) would reduce stroke frequency and mortality in patients with reversible cerebral ischemic attacks.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 5 April 2001.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Danish Medical Research Council

Trial Design

Cooperative, double-blind, placebo-controlled, randomized trial of 203 patients at 6 centers.

Contacts

Not available